In the OASIS 4 trial, oral semaglutide 25 mg taken once daily demonstrated 16.6% mean weight loss when treatment was adhered to in adult participants with obesity or overweight with one or more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results